| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of WFDC2 mRNA" | 21354444 |
| C490166 | 1-(4-methoxyphenyl)piperazine | 1-(4-methoxyphenyl)piperazine results in increased expression of WFDC2 mRNA | 26821219 |
| C078092 | 1-piperonylpiperazine | 1-piperonylpiperazine results in increased expression of WFDC2 mRNA | 26821219 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA" | 25510870 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA" | 25510870 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene affects the expression of WFDC2 mRNA" | 21346803 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of WFDC2 mRNA" | 25380136 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of WFDC2 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of WFDC2 mRNA | 21641981 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of WFDC2 mRNA | 16483693 |
| D001151 | Arsenic | Arsenic affects the methylation of WFDC2 gene | 25304211 |
| D001194 | Asbestos | Asbestos affects the expression of WFDC2 mRNA | 17297452 |
| C547126 | AZM551248 | AZM551248 results in decreased expression of WFDC2 mRNA | 22323515 |
| C487081 | belinostat | belinostat results in increased expression of WFDC2 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the expression of WFDC2 mRNA | 22342234 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of WFDC2 mRNA | 22228805 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of WFDC2 mRNA | 27195522 |
| D004958 | Estradiol | [Estradiol co-treated with Progesterone] results in decreased expression of WFDC2 mRNA | 20660070 |
| D004958 | Estradiol | Estradiol results in increased expression of WFDC2 mRNA | 15289156|1948475 |
| C006780 | bisphenol A | bisphenol A affects the expression of WFDC2 mRNA | 25181051 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of WFDC2 mRNA | 25979313 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of WFDC2 mRNA | 28472532 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of WFDC2 mRNA | 18353800 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of WFDC2 mRNA | 17553155 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of WFDC2 mRNA | 24386269 |
| D003300 | Copper | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of WFDC2 mRNA | 15467011 |
| C014347 | decitabine | decitabine affects the expression of WFDC2 mRNA | 23300844 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of WFDC2 mRNA] | 27941970 |
| D003976 | Diazinon | Diazinon results in increased methylation of WFDC2 gene | 22964155 |
| D002945 | Cisplatin | Cisplatin affects the expression of WFDC2 mRNA | 23300844 |
| D002945 | Cisplatin | WFDC2 protein affects the susceptibility to Cisplatin | 16217747 |
| D004041 | Dietary Fats | Dietary Fats affects the expression of WFDC2 mRNA | 19680557 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of WFDC2 mRNA | 22609946 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of WFDC2 mRNA | 24535843 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in decreased expression of WFDC2 mRNA | 15171707 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of WFDC2 mRNA | 15289156 |
| D002117 | Calcitriol | Calcitriol results in increased expression of WFDC2 mRNA | 26485663 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of WFDC2 mRNA | 25380136 |
| D004237 | Diuron | Diuron results in decreased expression of WFDC2 mRNA | 21551480 |
| C118739 | entinostat | entinostat results in increased expression of WFDC2 mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| D000431 | Ethanol | Ethanol results in increased expression of WFDC2 mRNA | 19167417 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of WFDC2 mRNA | 17555576 |
| D004397 | Fonofos | Fonofos results in increased methylation of WFDC2 promoter | 22847954 |
| D019833 | Genistein | Genistein results in increased expression of WFDC2 mRNA | 15289156 |
| D006533 | Heptachlor | Heptachlor results in decreased expression of WFDC2 mRNA | 23153324 |
| D017313 | Fenretinide | Fenretinide results in increased expression of WFDC2 mRNA | 28973697 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of WFDC2 mRNA | 25613284 |
| D007559 | Ivermectin | Ivermectin results in decreased expression of WFDC2 mRNA | 26443706 |
| D007854 | Lead | Lead affects the expression of WFDC2 mRNA | 28903495 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of WFDC2 mRNA | 27339419 |
| D015122 | Mercaptopurine | Mercaptopurine results in decreased expression of WFDC2 mRNA | 23358152 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of WFDC2 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of WFDC2 mRNA | 26011545 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of WFDC2 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased secretion of WFDC2 protein" | 25598225 |
| C461488 | N-benzylpiperazine | N-benzylpiperazine results in increased expression of WFDC2 mRNA | 26821219 |
| D000073878 | Palm Oil | Palm Oil affects the expression of WFDC2 mRNA | 19680557 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of WFDC2 mRNA | 26272509 |
| D010278 | Parathion | Parathion results in increased methylation of WFDC2 promoter | 22847954 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of WFDC2 protein | 17520064 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WFDC2 mRNA" | 25510870 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of WFDC2 mRNA | 24535843 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of WFDC2 mRNA] | 19482888 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of WFDC2 mRNA | 23091169 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of WFDC2 mRNA | 19482888 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of WFDC2 mRNA | 26272509 |
| D010795 | Phthalic Acids | Phthalic Acids results in decreased expression of WFDC2 mRNA | 15728792 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of WFDC2 mRNA | 23811191 |
| D011374 | Progesterone | [Estradiol co-treated with Progesterone] results in decreased expression of WFDC2 mRNA | 20660070 |
| D011374 | Progesterone | Progesterone results in decreased expression of WFDC2 mRNA | 21540246 |
| D011374 | Progesterone | Progesterone results in decreased expression of WFDC2 mRNA | 19690047 |
| C045950 | propiconazole | propiconazole results in decreased expression of WFDC2 mRNA | 21278054 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of WFDC2 mRNA | 24780913 |
| D054328 | Proton Pump Inhibitors | Proton Pump Inhibitors results in decreased expression of WFDC2 mRNA | 25626140 |
| C059514 | resveratrol | resveratrol results in increased expression of WFDC2 mRNA | 17257620 |
| D012643 | Selenium | Selenium results in increased expression of WFDC2 mRNA | 19244175 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of WFDC2 mRNA | 25895662 |
| D012906 | Smoke | Smoke results in decreased expression of WFDC2 mRNA | 21095227 |
| D012906 | Smoke | Smoke affects the expression of WFDC2 mRNA | 23693141 |
| C013698 | tallow | tallow affects the expression of WFDC2 mRNA | 19680557 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of WFDC2 mRNA | 17555576 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of WFDC2 mRNA | 25123088 |
| C021751 | tanshinone | tanshinone results in increased expression of WFDC2 mRNA | 15849732 |
| C012568 | terbufos | terbufos results in increased methylation of WFDC2 promoter | 22847954 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of WFDC2 mRNA | 12377990 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of WFDC2 mRNA | 28922406 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of WFDC2 mRNA | 21215274 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of WFDC2 mRNA | 25613284 |
| D014050 | Toluene | Toluene results in decreased expression of WFDC2 mRNA | 22967744 |
| D014212 | Tretinoin | Tretinoin results in increased expression of WFDC2 mRNA | 16249480 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of WFDC2 mRNA | 24935251|2627250 |
| D014501 | Uranium | Uranium affects the expression of WFDC2 mRNA | 15672453 |
| C005460 | uranyl acetate | uranyl acetate affects the expression of WFDC2 mRNA | 15672453 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WFDC2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of WFDC2 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of WFDC2 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of WFDC2 gene | 29154799 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of WFDC2 mRNA | 18930951 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of WFDC2 gene | 25560391 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of WFDC2 protein | 17520064 |
| C025643 | vinclozolin | vinclozolin affects the expression of WFDC2 mRNA | 19015723 |
| D014810 | Vitamin E | Vitamin E results in increased expression of WFDC2 mRNA | 19244175 |